Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Leukemia 32Leukemia, Myeloid, Acute 20Lymphoma 19Lymphoma, Follicular 18Breast Neoplasms 18Congenital Abnormalities 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma, Mantle-Cell 13Lymphoma, Large-Cell, Immunoblastic 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma, B-Cell, Marginal Zone 13Carcinoma, Non-Small-Cell Lung 13Hodgkin Disease 12Head and Neck Neoplasms 12Burkitt Lymphoma 12Lymphoma, Non-Hodgkin 11Colonic Neoplasms 11Multiple Myeloma 10Lung Neoplasms 10Leukemia, Myeloid, Chronic-Phase 10Squamous Cell Carcinoma of Head and Neck 9Rectal Neoplasms 9Neuroblastoma 9Melanoma 9Lymphoma, T-Cell, Cutaneous 9Colorectal Neoplasms 9Sezary Syndrome 8Sarcoma 8Myeloproliferative Disorders 8

Interventions

Carboplatin 31Paclitaxel 26Radiotherapy 23Bevacizumab 19Erlotinib Hydrochloride 16Cisplatin 14Gemcitabine 12Gefitinib 11Docetaxel 11Taxes 9Pemetrexed 9Etoposide 5pegfilgrastim 4Radiotherapy, Conformal 4Radiation 4Neoadjuvant Therapy 4Chemotherapy, Adjuvant 4Cetuximab 4Vinorelbine 3Amplified Fragment Length Polymorphism Analysis 3Topotecan 2Thalidomide 2Sorafenib 2Radiosurgery 2Pharmacogenomic Testing 2Nivolumab 2Magnetic Resonance Spectroscopy 2Irinotecan 2Gene Expression Profiling 2Filgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Bronchiolo-Alveolar × Polymerase Chain Reaction × Clear all
NCT00900172 2017-05-19

Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

Eastern Cooperative Oncology Group

Completed
180 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡